Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Farrant

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
JAMA Network Open|September 7, 2019
Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary AnalysisMary Farrant, J Donald Easton, Eric E Adelman, et al.
Stroke|June 23, 2020
Efficacy of Clopidogrel for Prevention of Stroke Based on <i>CYP2C19</i> Allele Status in the POINT TrialJames F Meschia, Ronald L Walton, Luca P Farrugia, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
JAMA Network Open|September 7, 2019
Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary AnalysisMary Farrant, J Donald Easton, Eric E Adelman, et al.
Stroke|June 23, 2020
Efficacy of Clopidogrel for Prevention of Stroke Based on <i>CYP2C19</i> Allele Status in the POINT TrialJames F Meschia, Ronald L Walton, Luca P Farrugia, et al.
Pageof 2